Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Enable Therapeutics LLC — Funding, Investors & Profile — Capbase

← All companies

Compare History

Enable Therapeutics LLC

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

DUNS: 117592861

Founded: —Source: [GOV]
Headquarters: Hopedale, MassachusettsSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Enable Therapeutics LLC has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $701,056 in 2021. These are non-dilutive federal research grants, not equity financing. The company is based in Hopedale, Massachusetts.

Funding rounds

2 rounds

STTR Phase I award (HHS)GrantFeb 2021Source: [GOV]
$450K
—post-money
SBIR Phase I award (NSF)

Investors

No investors recorded yet for Enable Therapeutics LLC.

Add an investor

People

Leadership

Robert ShafferPrincipal investigatorSince 2021Source: [GOV]

Acquisitions

Enable Therapeutics LLC has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Enable Therapeutics LLC.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

May 2021Source: [GOV]

$251K

—post-money